The Gut and Energy Balance: Visceral Allies in the Obesity Wars
暂无分享,去创建一个
[1] 刘金明,et al. IL-13受体α2降低血吸虫病肉芽肿的炎症反应并延长宿主存活时间[英]/Mentink-Kane MM,Cheever AW,Thompson RW,et al//Proc Natl Acad Sci U S A , 2005 .
[2] T. Moran,et al. Peptide YY(3-36) inhibits gastric emptying and produces acute reductions in food intake in rhesus monkeys. , 2005, American journal of physiology. Regulatory, integrative and comparative physiology.
[3] M. Matsuda,et al. Visfatin: A Protein Secreted by Visceral Fat That Mimics the Effects of Insulin , 2005, Science.
[4] J. Rungby,et al. Amylin agonists: a novel approach in the treatment of diabetes. , 2004, Diabetes.
[5] M. Reilly,et al. An Inflammatory Cascade Leading to Hyperresistinemia in Humans , 2004, PLoS medicine.
[6] J. Flier,et al. Suppressor of Cytokine Signaling 3 Is a Physiological Regulator of Adipocyte Insulin Signaling* , 2004, Journal of Biological Chemistry.
[7] H. Bays. Current and investigational antiobesity agents and obesity therapeutic treatment targets. , 2004, Obesity research.
[8] D. Drucker,et al. Oxyntomodulin and glucagon-like peptide-1 differentially regulate murine food intake and energy expenditure. , 2004, Gastroenterology.
[9] J. Flier,et al. Enhanced leptin sensitivity and attenuation of diet-induced obesity in mice with haploinsufficiency of Socs3 , 2004, Nature Medicine.
[10] G. Frost,et al. Ghrelin increases energy intake in cancer patients with impaired appetite: acute, randomized, placebo-controlled trial. , 2004, The Journal of clinical endocrinology and metabolism.
[11] J. Flier,et al. Adipose tissue as an endocrine organ. , 2004, The Journal of clinical endocrinology and metabolism.
[12] Mohammad A Ghatei,et al. Peripheral oxyntomodulin reduces food intake and body weight gain in rats. , 2004, Endocrinology.
[13] Hui Zheng,et al. Ghrelin stimulation of growth hormone release and appetite is mediated through the growth hormone secretagogue receptor. , 2004, Proceedings of the National Academy of Sciences of the United States of America.
[14] R. Steinbrook. Surgery for severe obesity. , 2004, The New England journal of medicine.
[15] J. Flier. Obesity Wars Molecular Progress Confronts an Expanding Epidemic , 2004, Cell.
[16] M. R. Nilsson,et al. Islet amyloid: a complication of islet dysfunction or an aetiological factor in Type 2 diabetes? , 2004, Diabetologia.
[17] A. Hirschberg,et al. Gastric pacing for morbid obesity: plasma levels of gastrointestinal peptides and leptin. , 2003, Obesity research.
[18] J. Holst,et al. Peripheral administration of GLP-2 to humans has no effect on gastric emptying or satiety , 2003, Regulatory Peptides.
[19] Yuxiang Sun,et al. Deletion of Ghrelin Impairs neither Growth nor Appetite , 2003, Molecular and Cellular Biology.
[20] Mohammad A Ghatei,et al. Oxyntomodulin suppresses appetite and reduces food intake in humans. , 2003, The Journal of clinical endocrinology and metabolism.
[21] Mohammad A Ghatei,et al. Inhibition of food intake in obese subjects by peptide YY3-36. , 2003, The New England journal of medicine.
[22] S. Gaetani,et al. Oleylethanolamide regulates feeding and body weight through activation of the nuclear receptor PPAR-α , 2003, Nature.
[23] H. Grill,et al. Hyperphagic effects of brainstem ghrelin administration. , 2003, Diabetes.
[24] G. Frost,et al. Pancreatic polypeptide reduces appetite and food intake in humans. , 2003, The Journal of clinical endocrinology and metabolism.
[25] H. Berthoud,et al. Gastric distension induces c-Fos in medullary GLP-1/2-containing neurons. , 2003, American journal of physiology. Regulatory, integrative and comparative physiology.
[26] M. Westerterp-Plantenga,et al. The effects of enterostatin intake on food intake and energy expenditure , 2003, British Journal of Nutrition.
[27] F. Reimann,et al. A novel glucose-sensing mechanism contributing to glucagon-like peptide-1 secretion from the GLUTag cell line. , 2003, Diabetes.
[28] Stanley Heshka,et al. Recombinant variant of ciliary neurotrophic factor for weight loss in obese adults: a randomized, dose-ranging study. , 2003, JAMA.
[29] D. Drucker,et al. Glucagon-Like Peptide-1-Responsive Catecholamine Neurons in the Area Postrema Link Peripheral Glucagon-Like Peptide-1 with Central Autonomic Control Sites , 2003, The Journal of Neuroscience.
[30] Noboru Murakami,et al. The role of the gastric afferent vagal nerve in ghrelin-induced feeding and growth hormone secretion in rats. , 2002, Gastroenterology.
[31] F. Reimann,et al. Glucose-sensing in glucagon-like peptide-1-secreting cells. , 2002, Diabetes.
[32] Rachel L. Batterham,et al. Gut hormone PYY3-36 physiologically inhibits food intake , 2002, Nature.
[33] Yuichiro Yamada,et al. Inhibition of gastric inhibitory polypeptide signaling prevents obesity , 2002, Nature Medicine.
[34] E. Dellinger,et al. Plasma ghrelin levels after diet-induced weight loss or gastric bypass surgery. , 2002, The New England journal of medicine.
[35] R. Reidelberger,et al. Effects of amylin-related peptides on food intake, meal patterns, and gastric emptying in rats. , 2002, American journal of physiology. Regulatory, integrative and comparative physiology.
[36] Young-Bum Kim,et al. PTP1B regulates leptin signal transduction in vivo. , 2002, Developmental cell.
[37] S. H. Young,et al. Expression of bitter taste receptors of the T2R family in the gastrointestinal tract and enteroendocrine STC-1 cells , 2002, Proceedings of the National Academy of Sciences of the United States of America.
[38] F. Lönnqvist,et al. A pilot study of long-term effects of a novel obesity treatment: omentectomy in connection with adjustable gastric banding , 2002, International Journal of Obesity.
[39] A. Asakawa,et al. Roles of pancreatic polypeptide in regulation of food intake , 2002, Peptides.
[40] J. Flier,et al. A Transgenic Model of Visceral Obesity and the Metabolic Syndrome , 2001, Science.
[41] P. J. Larsen,et al. Systemic administration of the long-acting GLP-1 derivative NN2211 induces lasting and reversible weight loss in both normal and obese rats. , 2001, Diabetes.
[42] D. Smith,et al. Oxyntomodulin inhibits food intake in the rat. , 2001, Endocrinology.
[43] A. Astrup,et al. A meta-analysis of the effect of glucagon-like peptide-1 (7-36) amide on ad libitum energy intake in humans. , 2001, The Journal of clinical endocrinology and metabolism.
[44] B. Wisse,et al. A preprandial rise in plasma ghrelin levels suggests a role in meal initiation in humans. , 2001, Diabetes.
[45] B. Portha,et al. Glucagon-like peptide-1 and exendin-4 stimulate beta-cell neogenesis in streptozotocin-treated newborn rats resulting in persistently improved glucose homeostasis at adult age. , 2001, Diabetes.
[46] M. Kurian,et al. The Use of Electrical Stimulation of the Vagus Nerve to Treat Morbid Obesity , 2001, Epilepsy & Behavior.
[47] T. Funahashi,et al. The Journal of Clinical Endocrinology & Metabolism Printed in U.S.A. Copyright © 2001 by The Endocrine Society Hypoadiponectinemia in Obesity and Type 2 Diabetes: Close Association with Insulin Resistance , 2022 .
[48] M. Lazar,et al. The hormone resistin links obesity to diabetes , 2001, Nature.
[49] M. Nakazato,et al. A role for ghrelin in the central regulation of feeding , 2001, Nature.
[50] G. Schwartz,et al. The role of gastrointestinal vagal afferents in the control of food intake: current prospects. , 2000, Nutrition.
[51] Rüdiger Klein,et al. Role of Brain Insulin Receptor in Control of Body Weight and Reproduction , 2000 .
[52] E. Brown,et al. L-amino acid sensing by the extracellular Ca2+-sensing receptor. , 2000, Proceedings of the National Academy of Sciences of the United States of America.
[53] M. Nakazato,et al. Ghrelin is a growth-hormone-releasing acylated peptide from stomach , 1999, Nature.
[54] A. Prentice,et al. Effects of recombinant leptin therapy in a child with congenital leptin deficiency. , 1999, The New England journal of medicine.
[55] A. Bado,et al. The stomach is a source of leptin , 1998, Nature.
[56] A. Joyner,et al. Glucose intolerance but normal satiety in mice with a null mutation in the glucagon–like peptide 1 receptor gene , 1996, Nature Medicine.
[57] C. Mantzoros,et al. Role of leptin in the neuroendocrine response to fasting , 1996, Nature.
[58] A. Mccarthy. Development , 1996, Current Opinion in Neurobiology.
[59] R. Pederson,et al. Degradation of glucose-dependent insulinotropic polypeptide and truncated glucagon-like peptide 1 in vitro and in vivo by dipeptidyl peptidase IV. , 1995, Endocrinology.
[60] Steven L. Cohen,et al. Weight-reducing effects of the plasma protein encoded by the obese gene. , 1995, Science.
[61] M. Maffei,et al. Positional cloning of the mouse obese gene and its human homologue , 1994, Nature.
[62] A. Masclee,et al. Bombesin reduces food intake in lean man by a cholecystokinin-independent mechanism. , 1993, The Journal of clinical endocrinology and metabolism.
[63] F. Pi‐Sunyer,et al. Effects of cholecystokinin-octapeptide (CCK-8) on food intake and gastric emptying in man , 1988, Physiology & Behavior.
[64] I. Forgacs. GASTROENTEROLOGY , 1988, The Lancet.
[65] S. Bloom,et al. GLUCAGON-LIKE PEPTIDE-1 7-36: A PHYSIOLOGICAL INCRETIN IN MAN , 1987, The Lancet.
[66] G. P. Smith,et al. Abdominal vagotomy blocks the satiety effect of cholecystokinin in the rat. , 1981, Science.
[67] S. Woods,et al. Peptides and the control of meal size , 1981, Diabetologia.
[68] C. Baile,et al. Obese mice and the satiety effects of cholecystokinin, bombesin and pancreatic polypeptide , 1981, Physiology & Behavior.
[69] T. Emery,et al. Peptides , 1964, Peptides.
[70] Anne Hardy,et al. Nutrition , 1941, The Lancet.
[71] G. Tsujimoto,et al. Free fatty acids regulate gut incretin glucagon-like peptide-1 secretion through GPR120 , 2005, Nature Medicine.
[72] Jiande D. Z. Chen,et al. Pyloric electrical stimulation reduces food intake by inhibiting gastric motility in dogs. , 2005, Gastroenterology.
[73] M. Bessler,et al. Effects of Roux-en-Y gastric bypass surgery on fasting and postprandial concentrations of plasma ghrelin, peptide YY, and insulin. , 2005, The Journal of clinical endocrinology and metabolism.
[74] B. Wolfe,et al. Surgical treatment of obesity: pyloric electrical stimulation. , 2005, Gastroenterology.
[75] S. Woods,et al. Insulin and leptin as adiposity signals. , 2004, Recent progress in hormone research.
[76] S. Bloom,et al. Repeated Intracerebroventricular Administration of Glucagon-Like Peptide-1-(7-36) Amide or Exendin-(9-39) Alters Body Weight in the Rat* *This work was supported by the United Kingdom Medical Research Council. , 1999, Endocrinology.